Kritchevsky D, Klurfeld D M
Pharmacol Res Commun. 1984 Feb;16(2):111-5. doi: 10.1016/s0031-6989(84)80085-5.
The effects of two levels (50 and 167 mg/kg) of a new hypocholesterolemic drug (EMD 34853) on gallstone formation in hamsters were investigated. Lithogenicity was inhibited by 28-45%. Levels of biliary lipids (cholesterol, phospholipid, bile acids) were reduced in the drug-treated animals.
研究了一种新型降胆固醇药物(EMD 34853)的两个剂量水平(50和167毫克/千克)对仓鼠胆结石形成的影响。结石形成能力受到28%-45%的抑制。药物治疗组动物的胆汁脂质(胆固醇、磷脂、胆汁酸)水平降低。